fbpx
GeneralResearch & Publications

Obesity, leptin resistance, and the effects of insulin reduction

By October 10, 2004September 24th, 2020No Comments

LINK TO RESEARCH
https://pubmed.ncbi.nlm.nih.gov/15314628/

PUBLICATION
International journal of obesity and related metabolic disorders

AUTHORS
R H Lustig 1 ,
S Sen,
J E Soberman,
P A Velasquez-Mieyer

ABSTRACT
Leptin resistance is a hallmark of obesity, but its etiology is unknown,
and its clinical measurement is elusive. Leptin-sensitive subjects have
normal resting energy expenditure (REE) at a low leptin concentration,
while leptin-resistant subjects have a normal REE at a higher leptin
concentration; thus, the ratio of REE:Leptin may provide a surrogate index
of leptin sensitivity. We examined changes in REE and leptin in a cohort of
17 obese subjects during experimental weight loss therapy with the
insulin-suppressive agent octreotide-LAR, 40 mg i.m. q28d for 6 months. Six
subjects lost significant weight (>10%) and BMI (>-3 kg/m(2)) with a 34%
decline in leptin and a 46% decrease in insulin area under the curve (IAUC)
to oral glucose tolerance testing. These subjects maintained their
pretreatment REE, and thus exhibited a rise in REE:Leptin, while the other
11 showed minimal changes in each of these parameters. For the entire
cohort, the change in IAUC correlated negatively with the change in
REE:Leptin. These results suggest that the REE:Leptin ratio, while
derivative, may serve as a useful clinical indicator of changes in leptin
sensitivity within obese subjects. They also support the possibilities that
hyperinsulinemia may be a proximate cause of leptin resistance, and that
reduction of insulinemia may promote weight loss by improving leptin
sensitivity.

——–

Interested in this research and working with us? Please contact us here.